Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

387 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Methods for categorizing a prognostic variable in a multivariable setting.
Mazumdar M, Smith A, Bacik J. Mazumdar M, et al. Stat Med. 2003 Feb 28;22(4):559-71. doi: 10.1002/sim.1333. Stat Med. 2003. PMID: 12590414
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.
Motzer RJ, Murphy BA, Bacik J, Schwartz LH, Nanus DM, Mariani T, Loehrer P, Wilding G, Fairclough DL, Cella D, Mazumdar M. Motzer RJ, et al. J Clin Oncol. 2000 Aug;18(16):2972-80. doi: 10.1200/JCO.2000.18.16.2972. J Clin Oncol. 2000. PMID: 10944130 Clinical Trial.
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
Bajorin DF, Sarosdy MF, Pfister DG, Mazumdar M, Motzer RJ, Scher HI, Geller NL, Fair WR, Herr H, Sogani P, et al. Bajorin DF, et al. J Clin Oncol. 1993 Apr;11(4):598-606. doi: 10.1200/JCO.1993.11.4.598. J Clin Oncol. 1993. PMID: 8386751 Clinical Trial.
Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy.
Murphy BA, Motzer RJ, Mazumdar M, Vlamis V, Nisselbaum J, Bajorin D, Bosl GJ. Murphy BA, et al. Cancer. 1994 May 15;73(10):2520-6. doi: 10.1002/1097-0142(19940515)73:10<2520::aid-cncr2820731012>;2-r. Cancer. 1994. PMID: 7513603
Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up.
Minasian LM, Motzer RJ, Gluck L, Mazumdar M, Vlamis V, Krown SE. Minasian LM, et al. J Clin Oncol. 1993 Jul;11(7):1368-75. doi: 10.1200/JCO.1993.11.7.1368. J Clin Oncol. 1993. PMID: 8315435 Clinical Trial.
387 results
Jump to page